PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 10:39 AM ET

Sponsor Check › Sponsor group

AP

Aquinox Pharmaceuticals

One sponsor team, 2 deal companies · Richmond, British Columbia, Canada (as filed: A1)

Grouped because: 9 shared people, same business address (2 issuers), similar issuer names (2) · 2 issuers also list a director who sits on many unrelated issuers (not used to group) (automatic match from the filings) · not the same sponsor?

2deal companies
$14Mreported sold
14investors
10Form D filings
2010–2013active
0new, last 12 mo
Follow this sponsor groupLook further ↓

Data last updated Oct 23, 2026, 5:45 PM ET · Latest filing in this group Apr 2, 2013 · Courts (RECAP) last checked: Oct 24, 2026, 2:16 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Aquinox Pharmaceuticals is a sponsor group of 2 issuers that PartnerFacts links to one sponsor (shared people, same business address, similar issuer names; automatic match from the filings), filing 10 Form D filings between Apr 2010 and Apr 2013.

What this means One team, 2 deal companies, about 3 years of track record in SEC filings. We link the companies because the same people or address appear on their forms — tap "Request a correction" if that is wrong.

Combined reported sold: $14M to 14 investors (latest filing per issuer). Industries as reported: "Other" (2). Issuers are based in British Columbia, Canada (as filed: A1) (2).

What this means $14M raised across the group, about $1M per investor. Amounts come from each company's latest Form D; they are what the sponsor reported, not audited figures.

Principal people: Asish Xavier (2 issuers, director), Daniel Levitt (2 issuers, director), David J. Main (2 issuers, executive officer and director), Elaine Jones (2 issuers, director), Frank Holler (2 issuers, director) and 13 more.

What this means The person on the most companies is usually the one running the show; their page lists every deal.

Activity: 0 new offerings in the last 12 months; latest filing Apr 2, 2013.

What this means No new raise filed in the past year.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY), property records (NYC, FL, IL and TX counties) — none found.

What this means Nothing turned up where we looked (4 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 10 public filings for Aquinox Pharmaceuticals and found 15 differences: Form D filed 16 days after the first sale; No amendment in the last 12 months on an offering that may still be open; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Aquinox Pharmaceuticals has not run yet — it is joining a line of 58,317 names; searches run around the clock at the hosts' allowed rate. Searched so far: 654 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:16 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Aquinox Pharmaceuticals..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:16 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

No comparisons published

What is compared

No public statement by this sponsor group has been collected yet, so there is nothing to compare. Sources compared: the sponsor's own website (known from the issuer's own filings — Form C issuer website, EDGAR company profile — an approved profile claim or Form ADV Item 1.I of its matched adviser) · SEC Form D · SEC Form ADV (IAPD) · Internet Archive · No website is on file for this sponsor group yet.

15 differences found between the filings for Aquinox Pharmaceuticals (compared 10 filings on Oct 24, 2026)

Note · Mar 31, 2010 – Apr 16, 2010

Form D filed 16 days after the first sale — AQUINOX PHARMACEUTICALS INC

The filing says the first sale was Mar 31, 2010. The Form D was filed Apr 16, 2010 — 16 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 1 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Apr 16, 2010 ↗AQUINOX PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Note · Mar 19, 2013 – Apr 2, 2013

No amendment in the last 12 months on an offering that may still be open — AQUINOX PHARMACEUTICALS INC (latest filing Apr 2, 2013)

The latest filing for this offering is dated Apr 2, 2013 (first sale Mar 19, 2013). It reports $26 sold of $39 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Apr 2, 2013 ↗AQUINOX PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Note · Mar 19, 2013 – Apr 1, 2013

No amendment in the last 12 months on an offering that may still be open — AQUINOX PHARMACEUTICALS (USA) INC (latest filing Apr 1, 2013)

The latest filing for this offering is dated Apr 1, 2013 (first sale Mar 19, 2013). It reports $13,999,975 sold of $20,999,962 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Apr 1, 2013 ↗AQUINOX PHARMACEUTICALS (USA) INC — PartnerFacts page ↗
Sources
Note · Mar 31, 2010 – Apr 15, 2010

No amendment in the last 12 months on an offering that may still be open — AQUINOX PHARMACEUTICALS (USA) INC (latest filing Apr 15, 2010)

The latest filing for this offering is dated Apr 15, 2010 (first sale Mar 31, 2010). It reports $4,827,549 sold of $6,227,549 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Apr 15, 2010 ↗AQUINOX PHARMACEUTICALS (USA) INC — PartnerFacts page ↗
Sources
Note · Feb 11, 2011 – Sep 26, 2011

David J. Main's role changed at AQUINOX PHARMACEUTICALS (USA) INC: executive officer, director, promoter → executive officer, director

The Feb 11, 2011 filing lists David J. Main as executive officer, director, promoter; the Sep 26, 2011 Form D lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Feb 11, 2011 ↗Form D · Sep 26, 2011 ↗David J. Main — PartnerFacts page ↗AQUINOX PHARMACEUTICALS (USA) INC — PartnerFacts page ↗
Sources
Note · Feb 11, 2011 – Sep 26, 2011

David J. Main's role changed at AQUINOX PHARMACEUTICALS INC: executive officer, director, promoter → executive officer, director

The Feb 11, 2011 filing lists David J. Main as executive officer, director, promoter; the Sep 26, 2011 Form D lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Feb 11, 2011 ↗Form D · Sep 26, 2011 ↗David J. Main — PartnerFacts page ↗AQUINOX PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Note · Sep 26, 2011 – Apr 2, 2013

Dr. Elaine Jones is written 2 different ways on the filings

listed as "Dr. Elaine Jones" on the Sep 26, 2011 filing, and "Dr. Elain Jones" on the Apr 2, 2013 filing.

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Sep 26, 2011 ↗Form D · Apr 2, 2013 ↗Dr. Elaine Jones — PartnerFacts page ↗
Sources
Note · Apr 15, 2010 – Apr 1, 2013

David J. Main is written 2 different ways on the filings

listed as "David J. Main" on 8 filings (from Apr 15, 2010), and "David Main" on 2 filings (from Apr 1, 2013).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Apr 15, 2010 ↗Form D · Apr 1, 2013 ↗David J. Main — PartnerFacts page ↗
Sources
Note · Apr 15, 2010 – Sep 26, 2011

Kenneth Galbraith is written 2 different ways on the filings

listed as "Kenneth H. Galbraith" on 6 filings (from Apr 15, 2010), and "Kenneth Galbraith" on 4 filings (from Sep 26, 2011).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Apr 15, 2010 ↗Form D · Sep 26, 2011 ↗Kenneth Galbraith — PartnerFacts page ↗
Sources
Note · Apr 16, 2010 – Apr 2, 2013

Industry group changed between filings — AQUINOX PHARMACEUTICALS INC

"Pharmaceuticals" (Apr 16, 2010 to Sep 26, 2011); then "Other" (Apr 2, 2013).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Apr 16, 2010 ↗Form D · Apr 2, 2013 ↗AQUINOX PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Note · Apr 15, 2010 – Apr 1, 2013

Industry group changed between filings — AQUINOX PHARMACEUTICALS (USA) INC

"Pharmaceuticals" (Apr 15, 2010 to Sep 26, 2011); then "Other" (Apr 1, 2013).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Apr 15, 2010 ↗Form D · Apr 1, 2013 ↗AQUINOX PHARMACEUTICALS (USA) INC — PartnerFacts page ↗
Sources
Note · Jun 25, 2010 – Feb 11, 2011

Address moved from Vancouver, British Columbia, Canada (as filed: A1) to Richmond, British Columbia, Canada (as filed: A1) — AQUINOX PHARMACEUTICALS INC

The people listed on the Jun 25, 2010 filing give Vancouver, British Columbia, Canada (as filed: A1); on the Feb 11, 2011 filing they give Richmond, British Columbia, Canada (as filed: A1).

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jun 25, 2010 ↗Form D · Feb 11, 2011 ↗AQUINOX PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Note · Jun 25, 2010 – Feb 11, 2011

Address moved from Vancouver, British Columbia, Canada (as filed: A1) to Richmond, British Columbia, Canada (as filed: A1) — AQUINOX PHARMACEUTICALS (USA) INC

The people listed on the Jun 25, 2010 filing give Vancouver, British Columbia, Canada (as filed: A1); on the Feb 11, 2011 filing they give Richmond, British Columbia, Canada (as filed: A1).

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jun 25, 2010 ↗Form D · Feb 11, 2011 ↗AQUINOX PHARMACEUTICALS (USA) INC — PartnerFacts page ↗
Sources
Note · Apr 1, 2013 – Apr 2, 2013

Member companies were formed in 2 different states

Delaware (1), Canada (Federal Level) (1) — out of 2 member issuers. The odd ones out: AQUINOX PHARMACEUTICALS INC (Canada (Federal Level)).

What this means Sponsors often form each deal company in Delaware or Wyoming no matter where the property is. A mix is common; it just tells you which state's rules each company lives under.

Aquinox Pharmaceuticals — sponsor group page ↗AQUINOX PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Note · Apr 16, 2010 – Apr 2, 2013

Issuer used a different name before — AQUINOX PHARMACEUTICALS INC

SEC records list prior names for this filer: AquaGenyx Pharmaceuticals Inc.. The current name on file is "AQUINOX PHARMACEUTICALS INC".

What this means A name change is normal, but your documents may show the old name. Match the CIK, not just the name.

EDGAR filer page ↗AQUINOX PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

None reported on 10 offerings — no sales commissions, finder's fees or proceeds to insiders

Per-offering detail
Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Apr 2, 2013 D
AQUINOX PHARMACEUTICALS INC
File 021-194361
$0$0$0None listed on this filingEDGAR ↗
Apr 1, 2013 D
AQUINOX PHARMACEUTICALS (USA) INC
File 021-194308
$0$0$0None listed on this filingEDGAR ↗
Sep 26, 2011 D
AQUINOX PHARMACEUTICALS (USA) INC
File 021-166388
$0$0$0None listed on this filingEDGAR ↗
Sep 26, 2011 D
AQUINOX PHARMACEUTICALS INC
File 021-166389
$0$0$0None listed on this filingEDGAR ↗
Feb 11, 2011 D
AQUINOX PHARMACEUTICALS INC
File 021-155187
$0$0$0None listed on this filingEDGAR ↗
Feb 11, 2011 D
AQUINOX PHARMACEUTICALS (USA) INC
File 021-155188
$0$0$0None listed on this filingEDGAR ↗
Jun 25, 2010 D
AQUINOX PHARMACEUTICALS (USA) INC
File 021-144021
$0$0$0None listed on this filingEDGAR ↗
Jun 25, 2010 D
AQUINOX PHARMACEUTICALS INC
File 021-144022
$0$0$0None listed on this filingEDGAR ↗
Apr 16, 2010 D
AQUINOX PHARMACEUTICALS INC
File 021-140721
$0$0$0None listed on this filingEDGAR ↗
Apr 15, 2010 D
AQUINOX PHARMACEUTICALS (USA) INC
File 021-140699
$0$0$0None listed on this filingEDGAR ↗

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across all 2 issuers in this group — every filing in our index, latest filing per offering (SEC file number).

Property records 0 documents · 0 ownership records · last checked Oct 24, 2026, 10:16 AM ET · NYC and Cook County lookup still to run

0 recorded documents and 0 ownership records matched to Aquinox Pharmaceuticals in the sources searched.

Not found in sources searched as of Oct 24, 2026, 10:16 AM ET: Hillsborough County FL Clerk of Court Official Records daily index (publicrec.hillsclerk.com D/P/M files), 2 daily files (Oct 14, 2026 to Oct 15, 2026) — loaded Oct 23, 2026, 8:59 PM ET; Harris County TX (HCAD ownership rolls 2005–2026) — 1,032,426 records, loaded Oct 24, 2026, 8:00 AM ET; Dallas County TX (DCAD ownership rolls 2021–2027) — 285,535 records, loaded Oct 24, 2026, 8:20 AM ET; Hillsborough County FL (FL DOR 2026 ownership roll + Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026), Miami-Dade County FL (FL DOR 2026 ownership roll), Broward County FL (FL DOR 2026 ownership roll), Palm Beach County FL (FL DOR 2026 ownership roll) — 514,336 records, loaded Oct 24, 2026, 8:25 AM ET; King County WA (Assessor sale records 0000-00-00–2026-10-14; no owner-of-record names published) — 538,619 records, loaded Oct 24, 2026, 8:27 AM ET; Cook County IL (Assessor sale records 1982–2026 + ownership rolls 1999–2026) — 1,263,035 records, loaded Oct 24, 2026, 9:34 AM ET. Still to be looked up for this group: NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) · NYC PLUTO ownership via NYC Open Data (64uk-42ks) · Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp). Records in other counties, and recorder indexes we do not yet cover, were not searched.

Property records coverage: New York City (ACRIS recorded documents and PLUTO ownership, looked up per issuer when its page is viewed; re-checked when the page is viewed again more than 30 days after the last check); Harris County TX (ownership only, no deed, mortgage or sale records; HCAD ownership rolls 2005–2026); Dallas County TX (ownership only, no deed, mortgage or sale records; DCAD ownership rolls 2021–2027); Hillsborough County FL (FL DOR 2026 ownership roll + Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026), Miami-Dade County FL (FL DOR 2026 ownership roll), Broward County FL (FL DOR 2026 ownership roll), Palm Beach County FL (FL DOR 2026 ownership roll); King County WA (Assessor sale records 0000-00-00–2026-10-14; no owner-of-record names published); Cook County IL (Assessor sale records 1982–2026 + ownership rolls 1999–2026); also looked up per issuer when its page is viewed. Recorder indexes (party names on deeds, mortgages and liens) in TX, AZ, NV, CA and WA counties and outside the Clerk index in FL, mortgages and liens outside NYC and Hillsborough County, lis pendens and foreclosure notices everywhere, Los Angeles County CA, Clark County NV, New York City bulk pass (not finished; per-issuer lookups only so far), Maricopa County AZ (loader ready; commercial-purpose statement not yet filed), Salt Lake County UT, and all other counties are not covered — not searched. Last refresh by source: NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) Oct 24, 2026, 9:34 AM ET; Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp) Oct 24, 2026, 9:34 AM ET; Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp) Oct 24, 2026, 8:30 AM ET; King County WA Assessor Real Property Sales extract (EXTR_RPSale.csv) Oct 24, 2026, 8:27 AM ET; Florida DOR NAL roll (Palm Beach 60) Oct 24, 2026, 8:25 AM ET; Florida DOR NAL roll (Broward 16) Oct 24, 2026, 8:24 AM ET; Florida DOR NAL roll (Dade 23) Oct 24, 2026, 8:23 AM ET; Florida DOR NAL roll (Hillsborough 39) Oct 24, 2026, 8:21 AM ET; Dallas Central Appraisal District ACCOUNT_INFO.CSV Oct 24, 2026, 8:20 AM ET; Harris County Appraisal District real_acct.txt Oct 24, 2026, 8:00 AM ET; Hillsborough County FL Clerk daily index Oct 23, 2026, 8:59 PM ET. NYC and Cook County are also looked up per issuer when its page is viewed; the most recent such lookup on this site finished Oct 24, 2026, 3:30 AM ET. Parties are named as the recorder's index names them (role suffixes as recorded); no address, account number or trust date is shown for an individual, and individual owners of record (home ownership) are not matched or shown. Items still in human review are not shown.

Issuers in this group

Why each issuer is here is stated in the "Linked by" column. Low-confidence links are never shown — they wait for human review.

SourceIssuerLinked byLocationIndustryFilingsSold (max)InvestorsMin. investment (latest filing)Active
EDGAR ↗AP AQUINOX PHARMACEUTICALS (USA) INCshared people, same business address, similar issuer names, director listed on many unrelated issuers (not used to group)RICHMOND, British Columbia, Canada (as filed: A1)Other5$13,999,9757No minimum reported2010–2013
EDGAR ↗AP AQUINOX PHARMACEUTICALS INCshared people, same business address, similar issuer names, director listed on many unrelated issuers (not used to group)RICHMOND, British Columbia, Canada (as filed: A1)Other5$267No minimum reported2010–2013

Market context: not shown for these offerings — fewer than 30 Form D filings in the last 5 years share the offering's industry and exemption, or the exemption claimed is not Rule 506(b)/506(c). No ranking or score.

Timeline of offerings

SourceFiledIssuerFormIndustryOfferedSold
EDGAR ↗Apr 2, 2013AQUINOX PHARMACEUTICALS INCDOther$39$26
EDGAR ↗Apr 1, 2013AQUINOX PHARMACEUTICALS (USA) INCDOther$20,999,962$13,999,975
EDGAR ↗Sep 26, 2011AQUINOX PHARMACEUTICALS INCDPharmaceuticals$6$6
EDGAR ↗Sep 26, 2011AQUINOX PHARMACEUTICALS (USA) INCDPharmaceuticals$3,536,035$3,536,035
EDGAR ↗Feb 11, 2011AQUINOX PHARMACEUTICALS (USA) INCDPharmaceuticals$4,724,298$4,724,298
EDGAR ↗Feb 11, 2011AQUINOX PHARMACEUTICALS INCDPharmaceuticals$9$9
EDGAR ↗Jun 25, 2010AQUINOX PHARMACEUTICALS INCDPharmaceuticals$6$6
EDGAR ↗Jun 25, 2010AQUINOX PHARMACEUTICALS (USA) INCDPharmaceuticals$3,531,483$3,531,483
EDGAR ↗Apr 16, 2010AQUINOX PHARMACEUTICALS INCDPharmaceuticals$9$9
EDGAR ↗Apr 15, 2010AQUINOX PHARMACEUTICALS (USA) INCDPharmaceuticals$6,227,549$4,827,549

Activity: 0 new offerings in the last 12 months across all issuers in this group (new offering = a Form D that is not an amendment, D/A) · most recent filing Apr 2, 2013. Industry history, as reported on each offering's latest filing: Previous offerings: Pharmaceuticals (2010–2011). Latest offering: Other (2013; most recent Apr 2, 2013).

People across the group

NameRolesIssuers hereFirst → last listed
KG Kenneth GalbraithDirector2Apr 15, 2010 → Apr 2, 2013
DM David J. MainExecutive Officer, Director2Apr 15, 2010 → Apr 2, 2013
KA Kamran AlamExecutive Officer2Sep 26, 2011 → Apr 2, 2013
AX Asish XavierDirector2Apr 15, 2010 → Apr 1, 2013
DL Daniel LevittDirector2Apr 15, 2010 → Apr 1, 2013
EJ Elaine JonesDirector2Feb 11, 2011 → Apr 1, 2013
FH Frank HollerDirector2Feb 11, 2011 → Sep 26, 2011
SM Stephen MajlathExecutive Officer2Apr 15, 2010 → Feb 11, 2011
KL Kevin LeslieDirector2Apr 15, 2010 → Jun 25, 2010
DJ Dr. Elaine JonesDirector1Sep 26, 2011 → Apr 2, 2013
DX Dr. Asish XavierDirector1Sep 26, 2011 → Apr 2, 2013
DM Dr. Thomas MacRuryExecutive Officer1Sep 26, 2011 → Apr 2, 2013
DL Dr. Daniel LevinDirector1Apr 2, 2013 → Apr 2, 2013
DL Dr. Daniel LevittDirector1Sep 26, 2011 → Sep 26, 2011
DC David ChernoffExecutive Officer1Apr 16, 2010 → Feb 11, 2011
CS Csaba SzaboExecutive Officer1Feb 11, 2011 → Feb 11, 2011
TM Thomas MacRuryExecutive Officer1Feb 11, 2011 → Feb 11, 2011
TM Thomas MacRoryExecutive Officer1Apr 16, 2010 → Jun 25, 2010

Business registration (state registry / Secretary of State)

None of the 2 issuers has a record in the registries searched.

Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); KY (Kentucky Secretary of State — Business Entity Search (sosbes.sos.ky.gov), searched by issuer name, data as of Oct 24, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file). A registry listing is the state's own record of the entity; it says nothing about the offering itself.

Adviser registration (Form ADV)

Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched Aquinox Pharmaceuticals.

Meta advertising

No Meta Pixel ids or Facebook / Instagram page links on file for Aquinox Pharmaceuticals as of Oct 24, 2026 — the sponsor website is read for them once it is on file (runs automatically). Meta Ad Library: not searched by PartnerFacts (no API access); a one-tap Ad Library search is under Look further.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Public profiles and social

No website or social profile named in Aquinox Pharmaceuticals's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #331,237 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Export this report as PDF · Premium

Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".

Change history

No corrections have been requested for this page.

Request a correction

Free. Covers the grouping itself or any record shown here. Logged with status: received → under review → fixed / confirmed with source.

Sponsor response

Add a sourced explanation next to any fact. Reviewed before publishing.

Grouping is PartnerFacts' inference from public filings (shared related persons, management entities, business address). Everything else on this page is drawn from the filings themselves. Not the same sponsor? Request a correction.

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (outside the US (as filed: RICHMOND), A1). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn companies ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

OpenCorporates ↗